Big Banian Biotech Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 03-12-2024
- Paid Up Capital ₹ 3.00 M
as on 03-12-2024
- Company Age 28 Year, 9 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 1.25 Cr
as on 03-12-2024
- Satisfied Charges ₹ 2.95 M
as on 03-12-2024
- Revenue %
(FY 2021)
- Profit -198.83%
(FY 2021)
- Net Worth -10.05%
(FY 2021)
- Total Assets -5.64%
(FY 2021)
About Big Banian Biotech
The Corporate was formerly known as Kushal Floritech Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹1.25 Cr. The company has closed loans amounting to ₹2.95 M, as per Ministry of Corporate Affairs (MCA) records.
Dodda Reddy, Narendra Hegde, and Ena Hegde serve as directors at the Company.
- CIN/LLPIN
U01122KA1996PTC019973
- Company No.
019973
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Mar 1996
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- LocationBangalore, Karnataka
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Big Banian Biotech?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Dodda Reddy | Managing Director | 04-Apr-2009 | Current |
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Narendra Hegde | Director | 10-Jun-2020 | Current |
Ena Hegde | Director | 27-Sep-2021 | Current |
Financial Performance of Big Banian Biotech.
Big Banian Biotech Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 198.83% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
What is the Ownership and Shareholding Structure of Big Banian Biotech?
In 2021, Big Banian Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Bio Shore Enzymes Private LimitedActive 26 years 7 months
Narendra Hegde and Ena Hegde are mutual person
- Crescent Polymers Private LimitedActive 24 years 5 months
Narendra Hegde and Ena Hegde are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Corporation Bank Creation Date: 30 Mar 2011 | ₹1.25 Cr | Open |
K.S.F.C. Creation Date: 17 Jul 2000 | ₹2.95 M | Satisfied |
How Many Employees Work at Big Banian Biotech?
Unlock and access historical data on people associated with Big Banian Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Big Banian Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Big Banian Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.